Fonar Logo
diagnostic imaging management services

* FONAR is not responsible for the accuracy of information on these servers. This link is provided for your convenience only.

 

Fonar Financials Filed with the SEC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

 

SEC Accession No. 0000355019-24-000009

Filing Date
2024-02-14
Accepted
2024-02-14 17:13:55
Documents
63
Period of Report
2023-12-31
 
Interactive Data
Document Format Files
Seq Description Document Type
1 FORM 10-Q FOR THE PERIOD ENDED DECEMBER 31, 2023 fonar_10-q.htm iXBRL 10-Q
2 SECTION 302 CERTIFICATION fonar_exhibit-31.htm EX-31.1
3 SECTION 906 CERTIFICATION fonar_exhibit-32.htm EX-32.1
4 GRAPHIC fonar_logo.jpg GRAPHIC
  Complete submission text file 0000355019-24-000009.txt  
Data Files
Seq Description Document Type
5 XBRL SCHEMA FILE fonr-20231231.xsd EX-101.SCH
6 XBRL CALCULATION fonr-20231231_cal.xml EX-101.CAL
7 XBRL DEFINITION FILE fonr-20231231_def.xml EX-101.DEF
8 XBRL LABEL FILE fonr-20231231_lab.xml EX-101.LAB
9 XBRL PRESENTATION FILE fonr-20231231_pre.xml EX-101.PRE
54 EXTRACTED XBRL INSTANCE DOCUMENT fonar_10-q_htm.xml XML
       

FONAR CORPORATION (Filer) CIK: 0000355019

IRS No.: 112464137 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q| Act: 34 | File No.: 000-10248 | Film No.: 24640505
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences

Business Address

110 Marcus Drive
Melville, NY 11740
631-694-2929
Mailing Address

110 Marcus Drive
Melville, NY 11740